Emerging frontiers in virtual drug discovery: From quantum mechanical methods to deep learning approaches

Area of Science:

• Computational Chemistry and Cheminformatics
• Drug Discovery and Medicinal Chemistry

Background:

• Virtual screening (VS) methods are crucial for identifying hit and lead compounds in early drug discovery.
• VS can reduce costs and timelines, and target challenging sites like protein-protein interfaces.
• Significant progress has been made in VS methodology and technology recently.

Purpose of the Study:

• To provide an overview of recent advancements in virtual screening methodology and technology.
• To highlight the impact of new approaches on drug discovery efficiency and compound identification.

Main Methods:

• Review of ultra-large virtual screening (ULVS) approaches, screening billions of compounds.
• Integration of novel machine learning (ML) methods to reduce computational costs.
• Application of quantum-mechanical (QM) approaches to improve prediction accuracy for small molecule properties.

Main Results:

• Ultra-large virtual screening has proven effective in discovering highly potent hit compounds.
• Machine learning significantly reduces the computational expense of virtual screening.
• Quantum-mechanical methods enhance the accuracy of predicting small molecule properties.

Conclusions:

• Virtual screening, particularly with recent technological advancements, is a powerful tool for accelerating drug discovery.
• Emerging technologies like ML and QM are driving the field forward, improving both speed and accuracy.
• Continued innovation in VS is essential for tackling complex drug targets and optimizing compound discovery.